Literature DB >> 29433714

Malignant Pleural Effusion: From Diagnostics to Therapeutics.

Rachelle Asciak1, Najib M Rahman2.   

Abstract

Malignant pleural effusion is a common complication of cancer and denotes a poor prognosis. It usually presents with dyspnea and a unilateral large pleural effusion. Thoracic computed tomography scans and ultrasound are helpful in distinguishing malignant from benign effusions. Pleural fluid cytology is diagnostic in about 60% of cases. In cytology-negative disease, pleural biopsies are helpful. Current management is palliative. Previously, first-line treatment for recurrent symptomatic malignant pleural effusion was chest drain insertion and talc pleurodesis, with indwelling pleural catheter insertion reserved for patients with trapped lung or failed talc pleurodesis. However, catheter insertion is an increasingly acceptable first-line treatment.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dyspnea; Indwelling pleural catheter; Malignant pleural effusion; Malignant pleural effusion management; Pleural fluid cytology

Mesh:

Year:  2017        PMID: 29433714     DOI: 10.1016/j.ccm.2017.11.004

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  13 in total

1.  The efficiency of a clinical pathway to guide combined applications of interventional pulmonology in undiagnosed pleural effusions.

Authors:  Yuan Liu; Lili Geng; Jian Xu; Mei Sun; Na Gao; Jing Zhao; Xue Han; Xiaolin Zhang; Xiaohui Zhao; Ling Jiang; Junjun Zhao
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

Review 2.  Treatment of malignant pleural effusion.

Authors:  Ricardo Mingarini Terra; Alberto Jorge Monteiro Dela Vega
Journal:  J Vis Surg       Date:  2018-05-22

3.  GC-MS metabolomics identifies novel biomarkers to distinguish tuberculosis pleural effusion from malignant pleural effusion.

Authors:  Yongxia Liu; Bin Mei; Deying Chen; Long Cai
Journal:  J Clin Lab Anal       Date:  2021-02-02       Impact factor: 2.352

4.  Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.

Authors:  Xinying Li; Guannan Wu; Cen Chen; Yuan Zhao; Suhua Zhu; Xincui Song; Jie Yin; Tangfeng Lv; Yong Song
Journal:  Front Immunol       Date:  2021-12-13       Impact factor: 7.561

Review 5.  Prognostic biomarkers of malignant patients with pleural effusion: a systematic review and meta-analysis.

Authors:  Peng Peng; Yuan Yang; Juan Du; Kan Zhai; Huan-Zhong Shi
Journal:  Cancer Cell Int       Date:  2022-02-24       Impact factor: 5.722

Review 6.  [Role and Significance of Bioactive Substances in Sputum
 in the Diagnosis of Lung Cancer].

Authors:  Yuming Jin; Zixuan Chen; Quan Chen; Leihao Sha; Cheng Shen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-12-20

7.  The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.

Authors:  Ming-Fang Wu; Chih-An Lin; Tzu-Hang Yuan; Hsiang-Yuan Yeh; Sheng-Fang Su; Chin-Lin Guo; Gee-Chen Chang; Ker-Chau Li; Chao-Chi Ho; Huei-Wen Chen
Journal:  Cancer Immunol Immunother       Date:  2020-11-11       Impact factor: 6.968

8.  Development and Validation of a Scoring System for Early Diagnosis of Malignant Pleural Effusion Based on a Nomogram.

Authors:  Aihua Wu; Zhigang Liang; Songbo Yuan; Shanshan Wang; Weidong Peng; Yijun Mo; Jing Yang; Yanqing Liu
Journal:  Front Oncol       Date:  2021-12-07       Impact factor: 6.244

9.  Pleural effusions associated with squamous cell lung carcinoma have a low diagnostic yield and a poor prognosis.

Authors:  Michael Dorry; Kevin Davidson; Rajesh Dash; Rachel Jug; Jeffrey M Clarke; Andrew B Nixon; Kamran Mahmood
Journal:  Transl Lung Cancer Res       Date:  2021-06

Review 10.  [Progress of Liquid Biopsy in the Diagnosis and Treatment of Lung Cancer 
with Malignant Pleural Effusion].

Authors:  Hao Zeng; Panwen Tian; Weimin Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.